Skip to content

PTHS PTHS Change In Fair Value Of Convertible Debt

Change In Fair Value Of Convertible Debt at other companies

Lucid Diagnostics logo
Lucid DiagnosticsLUCD
-$1.86M+87.2%
Lucid Diagnostics logo
Lucid DiagnosticsLUCD
-$1.86M+87.2%
HTF
Heartflow, Inc. Common StockHTFL
-$1.28M
BioSig Technologies, Inc. logo
BioSig Technologies, Inc.STEX
-$1.75M
American Battery Technology Company logo
American Battery Technology CompanyABAT
$388.36K
VenHub Global, Inc.
 logo
VenHub Global, Inc. VHUB
$932.2K+1,414%

Other financials

Income statement

See full
Revenue$10.9M
Gross profit$9.2M
Operating income-$13.1M-614%
Net income-$10.2M-420%
EPS (diluted)-$3.09+3.7%

Balance sheet

See full
Cash & equivalents$32.0M+24,250%
Total debt$29.6M
Total equity$35.1M+937%
Total assets$145.4M+15,855%

Cash flow

See full
Operating cash flow-$13.1M-1,977%
CapEx$194.0K
Free cash flow-$13.3M-2,008%

Valuation

See full
Market cap$98.22M+75.4%
Enterprise value$95.89M
P/S3.6×

Profitability

See full
Gross margin79.6%
Operating margin-157.7%
Net margin-186.2%
FCF margin-60.8%

Returns & leverage

See full
Return on equity-333.8%
Debt / equity0.8×
Current ratio2.8×+2.6×

Where this comes from

Reported directly by PTHS in its filing.

Tagged under the XBRL concept pths:ChangeInFairValueOfConvertibleDebt.

The official record: PTHS’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about PTHS's change in fair value of convertible debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is PTHS's change in fair value of convertible debt?
PTHS (PTHS) reported change in fair value of convertible debt of $5.2M in Q1 2026.
What does change in fair value of convertible debt mean?
This metric captures the periodic fluctuations in the market valuation of debt instruments that can be converted into equity. These changes are driven by shifts in the company's stock price, volatility, and interest rate environments. It reflects the financial impact of the company's capital structure choices and the potential dilution risk associated with its financing arrangements.